RELARA

Welcome to the Brand page for “RELARA”, which is offered here for Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, periodontitis, oral mucousitis and bone and soft tissue regeneration; medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis; medicated beverages, powders, and gels for colonoscopies and endoscopic procedures; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations and substances for the treatment of skin and nail conditions, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections;radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, a device for delivering energy to the skin and its underlying tissues; lasers and radio frequency devices for medical and aesthetic treatment; medical devices, medical instruments designed for the non-invasive removal of human body fat using an external energy source;.

Its status is currently believed to be active. Its class is unavailable. “RELARA” is believed to be currently owned by “BAUSCH HEALTH IRELAND LIMITED”.